HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael Mullan Selected Research
Michael Mullan Research Topics
Disease
55
Alzheimer Disease (Alzheimer's Disease)
01/2023 - 01/2002
9
Cognitive Dysfunction
12/2023 - 01/2002
9
Brain Concussion (Cerebral Concussion)
01/2023 - 04/2014
7
Neuroinflammatory Diseases
06/2023 - 01/2013
7
Inflammation (Inflammations)
01/2022 - 04/2002
7
Amyloid Plaque
01/2010 - 09/2003
5
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2024 - 01/2018
5
Traumatic Brain Injuries (Traumatic Brain Injury)
01/2024 - 01/2012
5
Wounds and Injuries (Trauma)
06/2023 - 01/2014
5
Gliosis
01/2023 - 02/2006
5
Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2023 - 01/2014
4
Memory Disorders (Memory Loss)
01/2022 - 12/2004
4
Dementia (Dementias)
01/2018 - 11/2002
3
Craniocerebral Trauma (Head Injury)
01/2024 - 10/2021
3
Hypertension (High Blood Pressure)
01/2018 - 12/2004
2
Mitochondrial Diseases (Mitochondrial Disease)
01/2024 - 01/2021
2
Tauopathies
01/2024 - 01/2015
2
Fatigue
01/2021 - 01/2020
2
Demyelinating Diseases (Demyelinating Disease)
01/2016 - 04/2014
2
Neuroblastoma
09/2008 - 04/2002
2
Neoplasms (Cancer)
05/2005 - 05/2004
1
Autoimmune Diseases (Autoimmune Disease)
01/2021
1
Chronic Pain
01/2021
1
Nervous System Diseases (Neurological Disorders)
01/2021
1
Neurobehavioral Manifestations
01/2021
1
Pain (Aches)
01/2021
1
Headache (Headaches)
01/2021
1
Type 2 Diabetes Mellitus (MODY)
01/2019
1
Weight Loss (Weight Reduction)
01/2019
1
Frailty
01/2016
1
Amyloidosis
01/2015
Drug/Important Bio-Agent (IBA)
16
Apolipoproteins E (ApoE)
IBA
01/2024 - 01/2002
16
Amyloid beta-Peptides
IBA
12/2019 - 09/2002
13
Apolipoproteins
IBA
01/2023 - 01/2002
12
Peptides (Polypeptides)
IBA
06/2011 - 09/2002
11
Amyloid (Amyloid Fibrils)
IBA
12/2018 - 07/2004
10
Proteins (Proteins, Gene)
FDA Link
01/2024 - 09/2003
8
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2012
7
Lipids
IBA
01/2023 - 01/2018
5
Protein Isoforms (Isoforms)
IBA
01/2024 - 11/2002
5
Phospholipids (Phosphatides)
FDA Link
Generic
01/2023 - 12/2014
5
nilvadipine (Escor)
IBA
01/2020 - 10/2014
5
anatabine
IBA
01/2017 - 11/2011
4
Apolipoprotein E4
IBA
01/2024 - 01/2013
4
Cytokines
IBA
01/2023 - 01/2013
4
salicylhydroxamic acid (SHAM)
IBA
10/2021 - 04/2014
4
1,4-dihydropyridine (dihydropyridine)
IBA
01/2020 - 06/2011
4
CD40 Ligand (CD40L)
IBA
09/2008 - 07/2004
3
Arachidonic Acid (Vitamin F)
IBA
01/2023 - 01/2017
3
Calcium Channel Blockers (Blockers, Calcium Channel)
IBA
01/2020 - 04/2012
3
Amyloid Precursor Protein Secretases (beta-Secretase)
IBA
02/2011 - 05/2005
2
Brain-Derived Neurotrophic Factor (BDNF)
IBA
12/2023 - 01/2019
2
Oxylipins
IBA
01/2023 - 01/2021
2
Docosahexaenoic Acids
IBA
01/2022 - 01/2017
2
Metalloproteases (Metalloproteinases)
IBA
01/2021 - 11/2020
2
Syk Kinase
IBA
01/2019 - 01/2017
2
Ether (Diethyl Ether)
IBA
01/2016 - 12/2014
2
Antihypertensive Agents (Antihypertensives)
IBA
06/2011 - 11/2009
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
11/2009 - 04/2002
1
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
01/2024
1
Nerve Growth Factors (Neurotrophins)
IBA
12/2023
1
Inflammasomes
IBA
06/2023
1
Tensins
IBA
01/2023
1
Cytochrome P-450 Enzyme System (Cytochrome P450)
IBA
01/2023
1
Carnitine (L-Carnitine)
FDA Link
Generic
01/2023
1
anandamide (arachidonylethanolamide)
IBA
01/2023
1
Fatty Acids (Saturated Fatty Acids)
IBA
01/2023
1
trimethyloxamine (trimethylamine N-oxide)
IBA
01/2023
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
01/2023
1
Permethrin (Ambush)
FDA Link
Generic
10/2022
1
Nerve Agents
IBA
10/2022
1
Pesticides
IBA
10/2022
1
Pyridostigmine Bromide (Pyridostigmine)
FDA Link
Generic
10/2022
1
Lipase (Acid Lipase)
FDA Link
01/2022
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2022
1
Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
IBA
01/2022
1
Biotin (Vitamin H)
FDA Link
10/2021
1
Angiopoietin-1
IBA
10/2021
1
Caveolin 1
IBA
10/2021
1
Eukaryotic Initiation Factor-2 (EIF 2)
IBA
01/2021
1
Hazardous Substances (Hazardous Materials)
IBA
01/2021
1
nicotinamide-beta-riboside
IBA
01/2020
1
Sirtuin 1
IBA
01/2020
1
Sirtuins
IBA
01/2020
1
Lipoprotein Receptors (Lipoprotein Receptor)
IBA
12/2019
1
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
01/2019
1
Apolipoprotein E3
IBA
01/2019
1
Insulin (Novolin)
FDA Link
01/2019
1
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2019
1
Interleukin-6 (Interleukin 6)
IBA
01/2018
1
oleoylethanolamide
IBA
01/2018
1
erucylphosphocholine
IBA
01/2016
1
Epitopes
IBA
12/2014
1
Retinaldehyde (Retinal)
IBA
04/2014
Therapy/Procedure
3
Therapeutics
01/2019 - 06/2011
1
Drug Therapy (Chemotherapy)
10/2021
1
Euthanasia (Mercy Killing)
01/2020
1
Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2019
1
Treatment Delay
01/2017
1
Duration of Therapy
10/2014